J.Molner AS (OTSE:MOLNR) Accounts Receivable : €0.07 Mil (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is J.Molner AS Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. J.Molner AS's accounts receivables for the quarter that ended in Dec. 2023 was €0.07 Mil.

Accounts receivable can be measured by Days Sales Outstanding. J.Molner AS's Days Sales Outstanding for the quarter that ended in Dec. 2023 was 36.82.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. J.Molner AS's Net-Net Working Capital per share for the quarter that ended in Dec. 2023 was €-1.68.

J.Molner AS Accounts Receivable Historical Data

The historical data trend for J.Molner AS's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

J.Molner AS Accounts Receivable Chart

J.Molner AS Annual Data

Trend

Dec21

Dec22

Dec23

Accounts Receivable

0.06

0.07

J.Molner AS Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23
Accounts Receivable	0.06	0.14	-	0.12	0.07

J.Molner AS Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.

J.Molner AS Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

J.Molner AS's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0.07	/	0.347	*	91
=	36.82

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), J.Molner AS's accounts receivable are only considered to be worth 75% of book value:

J.Molner AS's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2023 is calculated as:

	Net-Net Working Capital Per Share
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(0.093	+	0.75 * 0.07	+	0.5 * 0.072	-	2.867
-	0	-	0)	/	1.6
=	-1.68

Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.

J.Molner AS Accounts Receivable Related Terms

Thank you for viewing the detailed overview of J.Molner AS's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.

J.Molner AS (OTSE:MOLNR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » J.Molner AS (OTSE:MOLNR) » Definitions » Accounts Receivable

Traded in Other Exchanges

N/A

Address

Akadeemia tee 21/5, Harju maakond, Tallinn, EST, 12618

Website

https://www.jmolner.com

J.Molner AS is an Estonia-based company. The company is engaged in research and development in the field of biotechnology. The activities of the Company are divided into two fields: 1) Chemistry analytical and development services for third parties; 2) Development of the Company's own line of generic pharmaceuticals.

J.Molner AS (OTSE:MOLNR) Headlines

No Headlines